These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20225688)

  • 21. The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.
    Kamal MA; Acosta EP; Kimberlin DW; Gibiansky L; Jester P; Niranjan V; Rath B; Clinch B; Sánchez PJ; Ampofo K; Whitley R; Rayner CR
    Clin Pharmacol Ther; 2014 Sep; 96(3):380-9. PubMed ID: 24865390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oseltamivir: cutaneous and neurological adverse effects in children.
    Prescrire Int; 2006 Oct; 15(85):182-3. PubMed ID: 17128526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic.
    Ward P; Small I; Smith J; Suter P; Dutkowski R
    J Antimicrob Chemother; 2005 Feb; 55 Suppl 1():i5-i21. PubMed ID: 15709056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Oseltamivir resistant avian influenza unsettling. Private hoarding of influenza agents a potential threat against public health].
    Uhnoo I; Linde A
    Lakartidningen; 2006 Feb 1-7; 103(5):298-300. PubMed ID: 16512569
    [No Abstract]   [Full Text] [Related]  

  • 25. [The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
    Uhnoo I; Bergquist C
    Lakartidningen; 2009 Jul 8-21; 106(28-29):1814-9. PubMed ID: 19685621
    [No Abstract]   [Full Text] [Related]  

  • 26. In brief: concerns about oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2015 Jan; 57(1460):14. PubMed ID: 25536909
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescent jump case in Japan associated with influenza but not oseltamivir.
    Terada K; Kawai Y; Monju A; Wakabayashi T; Ouchi K
    Pediatr Infect Dis J; 2008 Jan; 27(1):88-9. PubMed ID: 18162953
    [No Abstract]   [Full Text] [Related]  

  • 29. Ethical considerations regarding the administration of oseltamivir for infection control indications.
    Collins C; Drew R; Cormican M
    Clin Infect Dis; 2007 Jul; 45(1):133-4; author reply 134-5. PubMed ID: 17554715
    [No Abstract]   [Full Text] [Related]  

  • 30. Oseltamivir dose adjustment in an H1N1 patient requiring haemodialysis.
    Dolley-Hitze T; Verdier MC; Tribut O; Le Tulzo Y; Marqué S
    Intensive Care Med; 2010 Sep; 36(9):1618-9. PubMed ID: 20625883
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
    Smith JR; Sacks S
    Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oseltamivir-induced delirium in a geriatric patient.
    Kohen I
    Int J Geriatr Psychiatry; 2007 Sep; 22(9):935-6. PubMed ID: 17721896
    [No Abstract]   [Full Text] [Related]  

  • 33. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on treatment of influenza A and B with tamiflu.
    Montalto NJ
    Am Fam Physician; 2001 Feb; 63(4):635-6. PubMed ID: 11237078
    [No Abstract]   [Full Text] [Related]  

  • 35. Keeping alert to changes during the pandemic.
    Thompson C; Rolls S
    Nurs N Z; 2009 Aug; 15(7):30. PubMed ID: 19785327
    [No Abstract]   [Full Text] [Related]  

  • 36. Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2008 Jul; 34(ACS-3):1-46. PubMed ID: 18802991
    [No Abstract]   [Full Text] [Related]  

  • 37. Biodistribution and metabolism of the anti-influenza drug [11C]oseltamivir and its active metabolite [11C]Ro 64-0802 in mice.
    Hatori A; Arai T; Yanamoto K; Yamasaki T; Kawamura K; Yui J; Konno F; Nakao R; Suzuki K; Zhang MR
    Nucl Med Biol; 2009 Jan; 36(1):47-55. PubMed ID: 19181268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug usage in dialysis patients].
    Kawaguchi Y; Yamamoto H
    Nihon Rinsho; 1992 Jan; 50 Suppl():651-62. PubMed ID: 1578749
    [No Abstract]   [Full Text] [Related]  

  • 39. The mechanisms of delayed onset type adverse reactions to oseltamivir.
    Hama R
    Infect Dis (Lond); 2016 Sep; 48(9):651-60. PubMed ID: 27251370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oseltamivir (Tamiflu) unsafe in infants under 1 year old.
    Wooltorton E
    CMAJ; 2004 Feb; 170(3):336. PubMed ID: 14757668
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.